Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Polycythemia Vera × givinostat hydrochloride × Clear all

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Hydroxyurea 6 ruxolitinib 4 peginterferon alfa-2b 2 Phlebotomy 2 Early Intervention, Educational 2 Aspirin 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 pomalidomide 1 peginterferon alfa-2a 1 liposomal amphotericin B 1 givinostat hydrochloride 1 givinostat 1 bomedemstat 1 anagrelide 1 Pipobroman 1 Pharmacogenomic Testing 1 Ondansetron 1 N(4)-oleylcytosine arabinoside 1 Morphine 1 Lenalidomide 1 Ketamine 1 Interferons 1 Interferon-alpha 1 Hypericum extract LI 160 1 Fentanyl 1 Dextromethorphan 1 Asian ginseng 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06093672 2026-01-27

GIV-IN-PV

Italfarmaco

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡